Table 2.
Metabolism | Gene | Substrate | Regulation | Manner | Reference |
---|---|---|---|---|---|
phase 0 | NTCP | Bile acids | Suppression | Indirect effect | [51] |
OATP1B1 | Bile acid, xenobiotics | Suprression | Indirect effect | [147] | |
OATP1B3 | Bile acid, xenobiotics | Activation | Direct effect | [148] | |
Phase I | CYP3A4 | Bile acid, xenobiotics | Activation | Direct and indirect effect | [77,149] |
CYP7A1 | Cholesterol | Suprression | Indirect effect | [59] | |
CYP8B1 | Cholesterol | Suprression | Indirect effect | [68] | |
CYP27A1 | Cholesterol | Suprression | Indirect effect | [69] | |
Phase II | UGT1A1 | Bile acid, xenobiotics | Activation | Direct effect | [92] |
UGT2B4 | Bile acid, xenobiotics | Activation | Direct effect | [78] | |
UGT2B7 | Bile acid, xenobiotics | Suppression | Direct effect | [150] | |
SULT1a1 | Bile acid, xenobiotics | Activation | Direct effect | [92] | |
SULT1a2 | Bile acid, xenobiotics | Activation | Direct effect | [92] | |
SULT2A1 | Bile acid, xenobiotics | Activation | Direct effect | [80] | |
GSTα3 | xenobiotics | Activation | Direct effect | [92] | |
GSTα4 | xenobiotics | Activation | Direct effect | [92] | |
GSTμ1 | xenobiotics | Activation | Direct effect | [92] | |
GSTμ3 | xenobiotics | Activation | Direct effect | [92] | |
BACS | Bile acid | Activation | Direct effect | [151] | |
BAT | Bile acid | Activation | Direct and indirect effect | [151,152] | |
Phase III | BSEP | Bile acid | Activation | Direct effect | [86] |
MRP2 | Bile acid, xenobiotics | Activation | Direct and indirect effect | [153] | |
MDR3 | PC | Activation | Direct effect | [91] | |
OSTα | Bile acid | Activation | Direct effect | [33,34] | |
OSTβ | Bile acid | Activation | Direct effect | [33,34] | |
FABP6 | Bile acid | Activation | Direct effect | [30] | |
ASTB | Bile acid | Suppression | Indirect effect | [24] |